Study of a pd VWF/FVIII Concentrate, Biostate®, in Subjects With Von Willebrand Disease

80 IU vWF/kg administered as a bolus intravenous infusion on Day 1 and approximately Day 180

Frequency and dose will be determined by the Investigator based on the subjects clinical condition, previous VWF concentrate requirements, response to therapy, weight and reason for usage.